Q00960 (NMDE2_RAT) Rattus norvegicus (Rat)
Glutamate receptor ionotropic, NMDA 2B UniProtKBInterProSTRINGInteractive Modelling
1482 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of GluN1b-2B NMDAR complexed to Fab2 class1 |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor structure-Class Y |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor structure-Class X |
Heteromer P35439; | |||||
| Assess | ||||||
| Crystal Structure of GluN1a/GluN2B NMDA Receptor Ion Channel |
Heteromer P35439; | 3×NAG; 2×NAG; 1×NAG; 84×W; 2×GLY; 8×NAG; 2×QEL; 2×GLU; | ||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR in complex with Fab5 in non-active2-like conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution |
Heteromer P35439; | 2×NAG; 10×NAG; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution |
Heteromer P35439; | 2×NAG; 8×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR in complex with Fab5 in Non-active1 conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| Memantine-bound GluN1a-GluN2B NMDA receptors |
Heteromer P35439; | 3×NAG; 9×NAG; 1×377; | ||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR in complex with Fab5 active conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR complexed to Fab2 Non-active2-like |
Heteromer P35439; | |||||
| Assess | ||||||
| Glycine and glutamate bound GluN1a-GluN2B NMDA receptors in non-active 1 conformation at 2.97 Angst… |
Heteromer P35439; | 3×NAG; 8×NAG; 2×GLY; 2×GLU; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with GluN2B antagonist SDZ 220-040, class 1 |
Heteromer P35439; | 2×QGP; 2×NAG; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with GluN2B antagonist SDZ 220-040, class 2 |
Heteromer P35439; | 2×NAG; 2×QGP; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 |
Heteromer P35439; | 1×NAG; 4×NAG; 2×QGP; 1×QGM; | ||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR complexed to Fab2 non-active1-like |
Heteromer P35439; | |||||
| Assess | ||||||
| Phencyclidine-bound GluN1a-GluN2B NMDA receptors |
Heteromer P35439; | 2×NAG; 8×NAG; 1×1PC; | ||||
| Assess | ||||||
| S-(+)-ketamine bound GluN1a-GluN2B NMDA receptors at 3.69 Angstrom resolution |
Heteromer P35439; | 3×NAG; 7×NAG; 2×GLY; 2×GLU; 1×JC9; | ||||
| Assess | ||||||
| Cryo-EM structure of GluN1b-2B NMDAR in complex with Fab5 non-active2 conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 |
Heteromer P35439; | 2×NAG; 2×QGM; 8×NAG; 2×QGP; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in active conformation stabilized by inter-GluN1b-GluN2B subunit cross-… |
Heteromer P35439; | 4×NAG; 8×NAG; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor structure in non-active-2 conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 1 |
Heteromer P35439; | 2×NAG; 2×QGM; 2×NAG; | ||||
| Assess | ||||||
| GluN1-GluN2B NMDA receptors with exon 5 |
Heteromer P35439; | 6×NAG; 10×NAG; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in non-active-1 conformation |
Heteromer P35439; | |||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 |
Heteromer P35439; | 2×NAG; 2×QGM; 4×NAG; | ||||
| Assess | ||||||
| GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution |
Heteromer P35439; | 2×NAG; 4×NAG; | ||||
| Assess | ||||||
| GLUN1B-GLUN2B NMDA RECEPTOR IN ACTIVE CONFORMATION |
Heteromer P35439; | |||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 4×NAG; 1×NA; 6×CL; 1×HYS; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 3×NAG; 1×NA; 6×CL; 1×HX7; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 3×NAG; 1×NA; 5×CL; 1×T97; | ||||
| Assess | ||||||
| Crystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2B in comple… |
Heteromer A0A1L8F5J9; | 1×NAG; 1×NA; 5×NAG; 2×QEL; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 3×NAG; 1×NA; 6×CL; 1×T88; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 4×NAG; 1×NA; 6×CL; 1×HXM; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 4×NAG; 1×NA; 5×CL; 1×HZ4; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A8J0TPH2; | 1×NAG; 3×NAG; 1×NA; 1×YGW; | ||||
| Assess | ||||||
| Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor… |
Heteromer A0A1L8F5J9; | 1×NAG; 3×NAG; 1×NA; 6×CL; 1×HYY; | ||||
| Assess | ||||||
| Crystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2B in comple… |
Heteromer A0A1L8F5J9; | 1×NAG; 3×NAG; 1×NA; 1×QEM; | ||||
| Assess | ||||||
| Crystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2B in apo cl… |
Heteromer A0A1L8F5J9; | 4×NAG; | ||||
| Assess | ||||||
| Activation of NMDA receptors and the mechanism of inhibition by ifenprodil |
Heteromer A0A1L8F5J9; | |||||
| Assess | ||||||
| Crystal structure of GluN1b-2B ATD complexed to Fab5 anti-GluN2B antibody |
Heteromer A0A8J0TPH2; | |||||
| Assess | ||||||
| Crystal structure of amino terminal domain of the NMDA receptor subunit NR2B | monomer | 2×NAG; 17×CL; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of the zinc-bound amino terminal domain of the NMDA receptor subunit NR2B | monomer | 2×NAG; 5×CL; 1×NA; 5×ZN; | ||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7saa.1.B | monomer | 0.66 | 1×GLU; | 99.88 | ||
| Assess | ||||||
| 5ipq.1.B | monomer | 0.59 | 87.85 | |||
| Assess | ||||||
| 5ipr.1.B | monomer | 0.58 | 87.85 | |||
| Assess | ||||||
| 7eu7.1.C | monomer | 0.56 | 25.94 | |||
| Assess | ||||||